Genopathy
Gene-Disorder Association · Article
Gene
LOC126862707
MED14-Independent Group 3 Enhancer GRCh37_chr18:21452354-21453553
Disorder
Epidermolysis Bullosa, Junctional 2a, Intermediate
First reported 2002
Key publication · disorder Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.Human genetics · 2002
Association Review

In brief

The association between LOC126862707 (MED14-Independent Group 3 Enhancer GRCh37_chr18:21452354-21453553) and Epidermolysis Bullosa, Junctional 2a, Intermediate is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.

Sources 1
Clinical variants 2
Symptoms 10
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
LOC126862707

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Epidermolysis Bullosa, Junctional 2a, Intermediate

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

2 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access